Philippine Hospital Association
Home
Articles
Events
Gallery
About Us
Mission
Vision
Core Values
Contact Us
Become A Member
Board Of Directors
PRELIMINARY RECOMMENDATION FOR THE NON-INCLUSION OF PERTUZUMAB FOR HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE BREAST CANCER
Date Posted:
January 21, 2022
Share on Facebook
Share on Twitter
